Dihexa — is anyone actually running this safely
16 posts
Dihexa keeps coming up in nootropic circles as '7 orders of magnitude more potent than BDNF for synaptic formation.' That's the kind of claim that should make anyone pause. It's also never been in a human trial and the preclinical work is almost all from one lab.
I'm not planning to take it. I'm asking because I want to understand what 'running it safely' even means for a compound with no human data. Is it literally just 'low dose, hope for the best'?
6 Replies
53 posts
Mod reminder: we've had conversations about dihexa that crossed into encouraging unsupervised experimentation. Keep discussion to mechanism and risk framing, not 'here's how to dose it.'
- Sermorelin · 200 mcg · 5x/wk AM · sub-Q
- BPC-157 · 250 mcg · 2x/day · sub-Q
68 posts
The one-lab problem is the big flag. It's not that the work is bad, it's that nobody's replicated. For a compound this potent this would be Nobel territory if the claims held up independently. They haven't been tested independently.
- Epithalon · 10 mg · 10d on / 80d off · sub-Q
- MOTS-c · 5 mg · 2x/wk · sub-Q
- 5-Amino-1MQ · 150 mg · daily · oral
34 posts
33 posts
The replication issue is the actual problem here. One lab publishing crazy potency claims without independent validation is basically peer review working as intended, except nobody else has bothered to run the same experiments with proper controls. That's not a red flag, that's the absence of any flag at all. Until someone replicates it in a different lab with blinded dosing and actual baseline measurements, the "7 orders of magnitude" thing is just a number they measured in their system under their conditions. Could be real, could be artifact, could be they're measuring something totally different than what matters in vivo. The preclinical work being good doesn't mean it scales to humans or that it's even what we think it is at lower doses.
33 posts
The replication thing gets thrown around a lot but honestly, most novel compounds don't get independently replicated until someone commercially pushes them. That's just how biotech works. The real question is whether the mechanism makes sense at all, and from what I've read the BDNF potentiation angle is solid in theory. Doesn't mean you should take it obviously, but "one lab published it" isn't the slam dunk everyone thinks it is. Plenty of legit discoveries came from single labs first.
- Semaglutide · 1.7 mg · weekly · sub-Q